Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2025

Treating Underrepresented Patients With DME

Andres Emanuelli, MD

Show Description +

Dr. Emanuelli discusses 1-year data from the Elevatum trial, including the treatment response and safety of faricimab (Vabysmo, Genentech/Roche) in underrepresented patients with diabetic macular edema.

Posted: 6/04/2025

Keywords:

Clinical Trials

•

faricimab

•

vabysmo

•

Roche

•

Genentech

•

Elevatum

•

Diabetic macular edema, DME

•

retina-meeting-recap

Up Next

Treating DR with OTX-TKI

Treating DR with OTX-TKI

Katherine E. Talcott, MD

An Oral Option for Stargardt Disease: New Data

An Oral Option for Stargardt Disease: New Data

Kenneth C. Fan, MD, MBA

Optogenetics for RP: 126-Week Data

Optogenetics for RP: 126-Week Data

David S. Liao, MD, PhD

ILM Flaps: 10 Years of Data

ILM Flaps: 10 Years of Data

Zofia A. Nawrocka, MD, PhD

When to Treat with Pegcetacoplan

When to Treat with Pegcetacoplan

Roger A. Goldberg, MD, MBA

Treatment Burden: EYP-1901 Versus Aflibercept

Treatment Burden: EYP-1901 Versus Aflibercept

Avni P. Finn, MD, MBA

Pharmacodynamics of ABBV-RGX-314

Pharmacodynamics of ABBV-RGX-314

Robert L. Avery, MD

The PDS Versus Anti-VEGF Injections in the Fellow Eye

The PDS Versus Anti-VEGF Injections in the Fellow Eye

Jordan Graff, MD, FACS

UBX1325 For DME: Phase 2 Data

UBX1325 For DME: Phase 2 Data

Dante Pieramici, MD

Switching Agents in DME

Switching Agents in DME

Michael Javaheri, MD

Treating Underrepresented Patients With DME

Treating Underrepresented Patients With DME

Andres Emanuelli, MD

Back to All Videos

Treating Underrepresented Patients With DME

Andres Emanuelli, MD

Dr. Emanuelli discusses 1-year data from the Elevatum trial, including the treatment response and safety of faricimab (Vabysmo, Genentech/Roche) in underrepresented patients with diabetic macular edema.

Posted: 6/04/2025

Keywords:

Clinical Trials

•

faricimab

•

vabysmo

•

Roche

•

Genentech

•

Elevatum

•

Diabetic macular edema, DME

•

retina-meeting-recap

Please log in to leave a comment.

More From ASRS: 2025 Coverage

Treating DR with OTX-TKI

Treating DR with OTX-TKI

Katherine E. Talcott, MD

An Oral Option for Stargardt Disease: New Data

An Oral Option for Stargardt Disease: New Data

Kenneth C. Fan, MD, MBA

Optogenetics for RP: 126-Week Data

Optogenetics for RP: 126-Week Data

David S. Liao, MD, PhD

ILM Flaps: 10 Years of Data

ILM Flaps: 10 Years of Data

Zofia A. Nawrocka, MD, PhD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2025.